Testing effectiveness (Phase 2)Active Not RecruitingNCT07374003
What this trial is testing
Ipromlimab and Tuvonralimab Combined With Albumin-Bound Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
Who this might be right for
Locally Advanced, Resectable
Sun Yat-sen University 62